Anti-Tumor Effects of Peptide Therapeutic and Peptide Vaccine Antibody Co-targeting HER-1 and HER-2 in Esophageal Cancer (EC) and HER-1 and IGF-1R in Triple-Negative Breast Cancer (TNBC)

Despite the promise of targeted therapies, there remains an urgent need for effective treatment for esophageal cancer (EC) and triple-negative breast cancer (TNBC). Current FDA-approved drugs have significant problems of toxicity, safety, selectivity, efficacy and development of resistance. In this...

Descripción completa

Detalles Bibliográficos
Autores principales: Overholser, Jay, Ambegaokar, Kristen Henkins, Eze, Siobhan M., Sanabria-Figueroa, Eduardo, Nahta, Rita, Bekaii-Saab, Tanios, Kaumaya, Pravin T.P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4586465/
https://www.ncbi.nlm.nih.gov/pubmed/26350593
http://dx.doi.org/10.3390/vaccines3030519

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4586465/
https://www.ncbi.nlm.nih.gov/pubmed/26350593
http://dx.doi.org/10.3390/vaccines3030519

Ejemplares similares